Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Collegium Pharmaceutical (COLL) Shares Issued (2016 - 2026)

Collegium Pharmaceutical has reported Shares Issued over the past 10 years, most recently at $985000.0 for Q4 2025.

  • For Q4 2025, Shares Issued rose 110.65% year-over-year to $985000.0; the TTM value through Dec 2025 reached $4.3 million, up 417.53%, while the annual FY2025 figure was $4.3 million, 417.53% up from the prior year.
  • Shares Issued for Q4 2025 was $985000.0 at Collegium Pharmaceutical, down from $2.8 million in the prior quarter.
  • Over five years, Shares Issued peaked at $9.6 million in Q2 2024 and troughed at -$9.2 million in Q4 2024.
  • A 5-year average of $1.4 million and a median of $1.3 million in 2022 define the central range for Shares Issued.
  • Biggest five-year swings in Shares Issued: tumbled 213.02% in 2024 and later surged 1771.81% in 2025.
  • Year by year, Shares Issued stood at $2.3 million in 2021, then plummeted by 291.06% to -$4.5 million in 2022, then surged by 283.06% to $8.2 million in 2023, then tumbled by 213.02% to -$9.2 million in 2024, then soared by 110.65% to $985000.0 in 2025.
  • Business Quant data shows Shares Issued for COLL at $985000.0 in Q4 2025, $2.8 million in Q3 2025, and -$1.0 million in Q2 2025.